Our studies add to these findings by showing that, in the absence of micro-environmental influences, chemotherapy drives triple-negative tumor cell invasive behavior by selecting for highly invasive tumor cell subpopulations represented infrequently in the heterogeneous tumor and characterized by the expression of cell surface pro-N-cadherin. The gene discussed is CDH2; the disease is neoplasm.